Severe Cold And Cough Daytime
NDC Package 63868-290-06
Package Information
Severe Cold And Cough Daytime is •do not use more than directed•take every 4 hours; while symptoms persist. Marketed by Chain Drug Manufacturing Assn, this product is identified by NDC 63868-290 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 1659967 - acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Granules for Oral Solution
- RxCUI: 1659967 - acetaminophen 650 MG / dextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG Granules for Oral Solution
- RxCUI: 1659967 - acetaminophen 650 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Powder for Oral Solution
- RxCUI: 1659967 - APAP 650 MG / Dextromethorphan Hydrobromide 20 MG / Phenylephrine Hydrochloride 10 MG Granules for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63868 - Chain Drug Manufacturing Assn
- 63868-290 - Severe Cold And Cough Daytime
- 63868-290-06 - 6 PACKET in 1 CARTON / 1 POWDER, FOR SOLUTION in 1 PACKET
- 63868-290 - Severe Cold And Cough Daytime
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63868-290-06 identifies a specific commercial package of 6 packet in 1 carton / 1 powder, for solution in 1 packet of Severe Cold And Cough Daytime, labeled by Chain Drug Manufacturing Assn. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Manufacturing Assn on July 25, 2018. The current certification is valid through December 31, 2023.
How is this Chain Drug Manufacturing Assn product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868029006. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.